Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

Similar articles for PubMed (Select 23356882)

1.

Androgen modulates cardiac fibrosis contributing to gender differences on heart failure.

Chung CC, Kao YH, Chen YJ, Chen YJ.

Aging Male. 2013 Mar;16(1):22-7. doi: 10.3109/13685538.2012.754008. Epub 2013 Jan 28. Review.

PMID:
23356882
2.

Androgens contribute to sex differences in myocardial remodeling under pressure overload by a mechanism involving TGF-β.

Montalvo C, Villar AV, Merino D, García R, Ares M, Llano M, Cobo M, Hurlé MA, Nistal JF.

PLoS One. 2012;7(4):e35635. doi: 10.1371/journal.pone.0035635. Epub 2012 Apr 25.

3.

Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure.

Matsumoto T, Wada A, Tsutamoto T, Ohnishi M, Isono T, Kinoshita M.

Circulation. 2003 May 27;107(20):2555-8. Epub 2003 May 12.

4.

Role of transforming growth factor-beta in the progression of heart failure.

Lim H, Zhu YZ.

Cell Mol Life Sci. 2006 Nov;63(22):2584-96. Review.

PMID:
17013566
5.

Androgen receptor gene knockout male mice exhibit impaired cardiac growth and exacerbation of angiotensin II-induced cardiac fibrosis.

Ikeda Y, Aihara K, Sato T, Akaike M, Yoshizumi M, Suzaki Y, Izawa Y, Fujimura M, Hashizume S, Kato M, Yagi S, Tamaki T, Kawano H, Matsumoto T, Azuma H, Kato S, Matsumoto T.

J Biol Chem. 2005 Aug 19;280(33):29661-6. Epub 2005 Jun 16.

6.

Allopurinol attenuates oxidative stress and cardiac fibrosis in angiotensin II-induced cardiac diastolic dysfunction.

Jia N, Dong P, Ye Y, Qian C, Dai Q.

Cardiovasc Ther. 2012 Apr;30(2):117-23. doi: 10.1111/j.1755-5922.2010.00243.x. Epub 2010 Oct 26.

PMID:
20973927
7.

Iron chelation and a free radical scavenger suppress angiotensin II-induced upregulation of TGF-beta1 in the heart.

Saito K, Ishizaka N, Aizawa T, Sata M, Iso-o N, Noiri E, Mori I, Ohno M, Nagai R.

Am J Physiol Heart Circ Physiol. 2005 Apr;288(4):H1836-43. Epub 2004 Nov 18.

8.

Angiotensin II, transforming growth factor-beta1 and repair in the infarcted heart.

Sun Y, Zhang JQ, Zhang J, Ramires FJ.

J Mol Cell Cardiol. 1998 Aug;30(8):1559-69.

PMID:
9737942
9.

NADPH oxidase inhibition ameliorates cardiac dysfunction in rabbits with heart failure.

Liu Y, Huang H, Xia W, Tang Y, Li H, Huang C.

Mol Cell Biochem. 2010 Oct;343(1-2):143-53. doi: 10.1007/s11010-010-0508-4. Epub 2010 Jun 22.

PMID:
20567884
10.

Secretogranin II; a protein increased in the myocardium and circulation in heart failure with cardioprotective properties.

Røsjø H, Stridsberg M, Florholmen G, Stensløkken KO, Ottesen AH, Sjaastad I, Husberg C, Dahl MB, Øie E, Louch WE, Omland T, Christensen G.

PLoS One. 2012;7(5):e37401. doi: 10.1371/journal.pone.0037401. Epub 2012 May 24.

11.

Induction of cardiac fibrosis by transforming growth factor-beta(1).

Lijnen PJ, Petrov VV, Fagard RH.

Mol Genet Metab. 2000 Sep-Oct;71(1-2):418-35. Review.

PMID:
11001836
12.

Lipopolysaccharide induced activin A-follistatin imbalance affects cardiac fibrosis.

Zhang WQ, Yang CY, Li SM, Liu M, Ding M, Liu GH, Yang P.

Chin Med J (Engl). 2012 Jun;125(12):2205-12.

PMID:
22884154
13.

Heart-infiltrating prominin-1+/CD133+ progenitor cells represent the cellular source of transforming growth factor beta-mediated cardiac fibrosis in experimental autoimmune myocarditis.

Kania G, Blyszczuk P, Stein S, Valaperti A, Germano D, Dirnhofer S, Hunziker L, Matter CM, Eriksson U.

Circ Res. 2009 Aug 28;105(5):462-70. doi: 10.1161/CIRCRESAHA.109.196287. Epub 2009 Jul 23.

14.

Oxidative stress mediates cardiac fibrosis by enhancing transforming growth factor-beta1 in hypertensive rats.

Zhao W, Zhao T, Chen Y, Ahokas RA, Sun Y.

Mol Cell Biochem. 2008 Oct;317(1-2):43-50. doi: 10.1007/s11010-008-9803-8. Epub 2008 Jun 26.

PMID:
18581202
15.

Reply to the letter "androgens in cardiac fibrosis and other cardiovascular mechanisms".

Chung CC, Kao YH, Lu YY, Chen YJ.

Int J Cardiol. 2015 Mar 1;182:340-1. doi: 10.1016/j.ijcard.2014.12.130. Epub 2014 Dec 30. No abstract available.

PMID:
25585369
16.

Local angiotensin II aggravates cardiac remodeling in hypertension.

Xu J, Carretero OA, Liao TD, Peng H, Shesely EG, Xu J, Liu TS, Yang JJ, Reudelhuber TL, Yang XP.

Am J Physiol Heart Circ Physiol. 2010 Nov;299(5):H1328-38. doi: 10.1152/ajpheart.00538.2010. Epub 2010 Sep 10.

17.
18.

Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor-beta(1) transgene in the heart.

Nakajima H, Nakajima HO, Salcher O, Dittiè AS, Dembowsky K, Jing S, Field LJ.

Circ Res. 2000 Mar 17;86(5):571-9.

19.

CTGF expression is induced by TGF- beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis.

Chen MM, Lam A, Abraham JA, Schreiner GF, Joly AH.

J Mol Cell Cardiol. 2000 Oct;32(10):1805-19.

PMID:
11013125
20.

Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7).

Grobe JL, Mecca AP, Lingis M, Shenoy V, Bolton TA, Machado JM, Speth RC, Raizada MK, Katovich MJ.

Am J Physiol Heart Circ Physiol. 2007 Feb;292(2):H736-42. Epub 2006 Nov 10.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk